Related Experiment Videos
The intrahepatic cholangiopathies
1Department of Pediatrics, Mount Sinai School of Medicine, New York, New York 10029, USA.
Seminars in Liver Disease
|October 17, 1998
Summary
Pediatric liver diseases often injure intrahepatic biliary epithelial cells (cholangiocytes). Damage to these cells, though a small liver population, causes significant illness and death in children, highlighting the need for understanding cholangiopathies.
Area of Science:
- Pediatric Hepatology
- Biliary System Pathophysiology
- Cholangiocyte Biology
Background:
- Intrahepatic biliary epithelial cells (cholangiocytes) are central to pediatric liver disease.
- Despite comprising 3-5% of liver cells, cholangiocyte injury leads to significant morbidity and mortality.
- Understanding cholangiopathies is crucial for managing childhood liver disorders.
Purpose of the Study:
- To review advances in understanding the embryology and physiology of the intrahepatic biliary system.
- To emphasize progress aiding the comprehension of pathophysiology in pediatric biliary tract disorders.
- To provide an overview of disorders affecting the intrahepatic biliary tree in children.
Main Methods:
- Selective review of embryology and physiology of the intrahepatic biliary system.
- Discussion of common pediatric cholangiopathies, excluding biliary atresia (covered elsewhere).
- Synthesis of recent advances relevant to biliary tract disorder pathophysiology.
Main Results:
- Cholangiocytes are key targets in various congenital and acquired pediatric liver diseases.
- Progress in embryology and physiology offers insights into disease mechanisms.
- A framework for understanding diverse cholangiopathies affecting children is presented.
Conclusions:
- Injury to cholangiocytes is a critical factor in pediatric liver disease outcomes.
- Advances in basic science illuminate the pathophysiology of biliary tract disorders.
- Comprehensive understanding of the intrahepatic biliary system is vital for pediatric liver health.